This proposed ICBG (University of Illinois at Chicago/UIC-based China-Vietnam ICBG """"""""Bioactive Compounds"""""""") is a modified continuation of the UlC-based Vietnam-Laos ICBG Phase II """"""""Studies on Biodiversity of Vietnam and Laos."""""""" The thrust and long-term goal of the current application is the discovery of bioactive compounds, primarily from the biodiversity source materials originated from China and Vietnam, as candidates for drug development.
The specific aims of the application address long-term achievements as follows: (i) discovery of new drugs for therapies against HIV/AIDS, cancer, tuberculosis, and malaria from microbial diversity of Southwestern China, microbial and marine diversity of Nui Chua National Park NCNP (Vietnam), marine biodiversity of South China Sea, and UIC-ICBG Phase II legacy plant extracts;(ii) discovery of new cellulose-degrading and biofuel-producing microbial strains;(iii) advancing new knowledge and strengthening conservation efforts on marine and terrestrial biodiversity in NCNP;(iv) empowering coastal communities of NCNP to improve their living conditions through coral reef restoration, and through effort to increase eco-tourism to the area, and promoting capacity building and strengthening of the infrastructure of the partner institutions in China and Vietnam. To achieve the above stated aims, six fully integrated Associate Programs/AP will work in synergy: AP1 - Microbial Biodiversity (SW China and Vietnam);AP2 - Biodiversity Source Materials Acquisition, Conservation, and Economic Development in Nui Chua National Park (Vietnam);AP3 - Microbial Biofuel Exploration (Vietnam, SW China);AP4 - US-China Priority Diseases: Cancer and HIV/AIDS;AP5 - Drug Discovery Chemistry;AP6 - Vietnam-Priority Diseases: Tuberculosis and Malaria. These six APs will operate under the coordination of the GROUP PROGRAM based at UIC. The operation and functioning of this modified Phase III China-Vietnam ICBG """"""""Bioactive Compounds"""""""" will be subject to and guided by a Phase III Memorandum of Agreement (MOA), which is Amendment II of the Phase II MOA.

Public Health Relevance

Cancer and HIV/AIDS are priority diseases in the United States, China, and globally, while tuberculosis and malaria are serious and priority diseases in Vietnam, and in other developing countries. Discovery and development by this ICBG of clinically useful agents for therapies against these diseases will significantly contribute to public health through the alleviation of human's sufferings and improvement of human welfare.

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01TW001015-12
Application #
7925755
Study Section
Special Emphasis Panel (ZRG1-ICP2-B (53))
Program Officer
Katz, Flora N
Project Start
1998-09-30
Project End
2012-08-31
Budget Start
2010-09-01
Budget End
2012-08-31
Support Year
12
Fiscal Year
2010
Total Cost
$400,000
Indirect Cost
Name
University of Illinois at Chicago
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
098987217
City
Chicago
State
IL
Country
United States
Zip Code
60612
Guan, Yifu; Wang, Dongying; Tan, Ghee T et al. (2016) Litsea Species as Potential Antiviral Plant Sources. Am J Chin Med 44:275-90
Guan, Yi-Fu; Song, Xun; Qiu, Ming-Hua et al. (2016) Bioassay-Guided Isolation and Structural Modification of the Anti-TB Resorcinols from Ardisia gigantifolia. Chem Biol Drug Des 88:293-301
Elkington, Bethany G; Sydara, Kongmany; Newsome, Andrew et al. (2014) New finding of an anti-TB compound in the genus Marsypopetalum (Annonaceae) from a traditional herbal remedy of Laos. J Ethnopharmacol 151:903-11
Pan, Wenhui; Liu, Kanglun; Guan, Yifu et al. (2014) Bioactive compounds from Vitex leptobotrys. J Nat Prod 77:663-7
Elkington, Bethany G; Sydara, Kongmany; Hartmann, John F et al. (2013) Folk Epidemiology Recorded in Palm Leaf Manuscripts of Laos. J Lao Stud 3:1-14
Soejarto, D D; Gyllenhaal, C; Kadushin, M R et al. (2012) An ethnobotanical survey of medicinal plants of Laos toward the discovery of bioactive compounds as potential candidates for pharmaceutical development. Pharm Biol 50:42-60
Gyllenhaal, C; Kadushin, M R; Southavong, B et al. (2012) Ethnobotanical approach versus random approach in the search for new bioactive compounds: support of a hypothesis. Pharm Biol 50:30-41
Truong, Ngan B; Pham, Cuong V; Doan, Huong T M et al. (2011) Antituberculosis cycloartane triterpenoids from Radermachera boniana. J Nat Prod 74:1318-22
Chlipala, George E; Pham, Huu Tri; Nguyen, Van Hung et al. (2010) Nhatrangins A and B, aplysiatoxin-related metabolites from the marine cyanobacterium Lyngbya majuscula from Vietnam. J Nat Prod 73:784-7
Elkington, Bethany G; Southavong, Bounhong; Sydara, Kongmany et al. (2009) Biological evaluation of plants of Laos used in the treatment of tuberculosis in Lao traditional medicine. Pharm Biol 47:26-33

Showing the most recent 10 out of 27 publications